Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 2, 2019

Primary Completion Date

April 2, 2020

Study Completion Date

July 7, 2022

Conditions

Bronchopulmonary Dysplasia

Interventions

BIOLOGICAL

Mesenchymal Stem Cell (MSC) therapy

3 doses of 5 million MSC will be administered

Trial Locations (4)

Hospital Universitario A Coruña, A Coruña

Hospital Clínico San Carlos, Madrid

Hospital Universitario La Paz, Madrid

Hospital Universitario y Politécnico La Fe, Valencia

All Listed Sponsors

collaborator

Instituto de Salud Carlos III

OTHER_GOV

collaborator

Fundación de Ayuda a la Investigación sobre la Hipertensión pulmonar

UNKNOWN

lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER

NCT02443961 - Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies | Biotech Hunter | Biotech Hunter